SCHD stock forecast, quote, news & analysis

Key Takeaways

• SCHD is a passively managed, index-based fund tracking the Dow Jones U.S. Dividend 100 Index, holding roughly 103 large-cap U.S. dividend payers.
• The fund carries a low 0.06% expense ratio, approximately $104 billion in assets, and a dividend yield near 3.3%.
• Portfolio exposure is concentrated in Health Care, Consumer Staples, Energy, Technology, and Financials—defensive, income-oriented sectors that have anchored recent returns.
• Over the trailing 30 days, SCHD advanced roughly 7%, and it posted a similar gain over the trailing quarter, reflecting a steady, trend-driven climb rather than sharp volatility.
• Key risks ahead include interest-rate shifts, sector rotation away from value and dividend equities, and earnings cycles among major health care and energy holdings.

Schwab U.S. Dividend Equity ETF (SCHD) Overview

The Schwab U.S. Dividend Equity ETF (SCHD) seeks to track the total return of the Dow Jones U.S. Dividend 100 Index, a benchmark of established U.S. companies selected for a record of consistent dividend payments and fundamental strength. Launched in 2011, the fund is passively managed and holds approximately 103 stocks, with more than 90% of assets typically invested in index constituents. It is one of the lowest-cost large-cap value funds available, with a net expense ratio of 0.06%.

The portfolio is heavily weighted toward large-cap value names. Health Care accounts for roughly 21% of assets, followed by Consumer Staples at about 20%, Energy near 14%, and Information Technology at roughly 12.7%. Financials, Industrials, and Consumer Discretionary round out the exposure. Among the largest positions are Abbott Laboratories (ABT), Amgen (AMGN), Merck (MRK), Home Depot (HD), Coca-Cola (KO), and UnitedHealth Group (UNH).

This structure gives SCHD a defensive, income-oriented profile with lower historical volatility than the broad market. A beta of roughly 0.67 relative to the S&P 500 means the fund tends to move less than the broader equity market, which helps explain its relatively measured, steady price behavior.

Industry and Thematic Landscape

SCHD operates squarely within the large-cap value and dividend-investing themes that have drawn sustained investor interest. Demand for reliable income has kept dividend and quality-oriented strategies in focus, particularly in an environment where investors continue to weigh the durability of earnings against valuation levels across growth and technology segments.

Health care has been a notable source of strength, supported by resilient demand and firm pricing power among pharmaceutical and managed-care names. Consumer Staples companies such as Coca-Cola, PepsiCo (PEP), and Procter & Gamble (PG) provide steady cash flows that appeal to income investors during periods of uncertainty. Energy exposure through Chevron (CVX) and ConocoPhillips (COP) adds cyclical sensitivity tied to commodity prices and shareholder-return policies, while Financials contribute exposure to a rate-sensitive earnings cycle.

The broader backdrop—monetary policy, inflation trends, and the pace of economic growth—remains central to how dividend equities are valued relative to bonds and higher-growth alternatives. When yields on fixed income ease, the relative appeal of stable dividend payers tends to improve, a dynamic that has historically supported SCHD's style.

Performance and Positioning Snapshot

SCHD's recent price movement has been gradual and trend-driven rather than volatile. The fund climbed from roughly $32.80 in late July to about $35.11 in mid-to-late August, a gain of approximately 7% over the trailing 30 days. Over the trailing quarter, the fund advanced a comparable amount, moving from the low-$32 range to the mid-$35 range.

This measured advance reflects leadership from several of the fund's largest holdings. Health care stalwarts including Merck, UnitedHealth Group, and Amgen have contributed meaningfully, as have defensive consumer names and select energy positions. The fund's overweight to dividend-paying, cash-generative businesses has supported consistent accumulation, while its below-market beta has kept the path relatively smooth compared with more growth-sensitive equity segments.

Sector rotation has also played a role. As investors have balanced exposure across value, income, and quality, SCHD's composition has positioned it to capture flows that favor lower-valuation, higher-yield segments over higher-multiple growth leadership during periods of broad market reassessment.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. The tool is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening, allowing users to compare ETFs and equities across industries, performance characteristics, and risk metrics. For investors seeking to complement holdings such as SCHD with other income, value, or sector-specific ideas, the platform offers a data-driven way to narrow a broad universe. Explore the AI Screener to build and refine your own discovery workflow.

2026 Outlook and Key Factors to Monitor

Looking ahead, several structural factors are likely to shape SCHD's path through 2026. The trajectory of interest rates and inflation remains central, because dividend equities compete directly with fixed-income yields for investor capital. A declining-rate environment would generally enhance the relative appeal of the fund's income streams, while persistently elevated yields could temper demand.

The earnings cycles of the fund's largest health care, consumer staples, and energy holdings will also matter. Pharmaceutical pipelines, managed-care cost trends, commodity price direction, and consumer spending resilience are all variables that could influence constituent performance and sector leadership.

Capital flows into value and dividend strategies, ETF competition, and any policy or regulatory developments affecting large-cap U.S. equities round out the watchlist. Because SCHD's portfolio is concentrated in defensive, income-producing industries, its outlook is closely tied to the broader balance between income-seeking demand and shifts in investor preference toward higher-growth segments.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations